Osamu Muraoka Selected Research

salacinol

2/2015	Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis.
4/2009	Facile synthesis of de-O-sulfated salacinols: revision of the structure of neosalacinol, a potent alpha-glucosidase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Muraoka Research Topics

Disease

7	Experimental Melanoma 04/2018 - 02/2013
4	Carcinoma (Carcinomatosis) 01/2021 - 07/2016
4	Neoplasms (Cancer) 07/2017 - 01/2016
2	Body Weight (Weight, Body) 06/2019 - 02/2015
2	Leukemia 03/2018 - 12/2010
2	Melanoma (Melanoma, Malignant) 07/2017 - 01/2016
2	Multiple Myeloma 06/2016 - 05/2016
1	Obesity 06/2021
1	Hyperglycemia 01/2021
1	Hepatoblastoma 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2019
1	Hypersensitivity (Allergy) 03/2018
1	Starvation 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Rheumatoid Arthritis 01/2015
1	Wounds and Injuries (Trauma) 06/2014
1	Confusion (Bewilderment) 04/2009
1	Cross Infection (Nosocomial Infection) 09/2008
1	Strabismus (Squint) 04/2004

Drug/Important Bio-Agent (IBA)

7	Theophylline (Theon)FDA LinkGeneric 04/2018 - 02/2013
4	mangiferinIBA 06/2016 - 01/2015
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 02/2015
3	Methanol (Carbinol)IBA 03/2018 - 06/2014
3	NF-kappa B (NF-kB)IBA 05/2016 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2018 - 01/2015
2	Phosphotransferases (Kinase)IBA 05/2016 - 01/2016
2	salacinolIBA 02/2015 - 04/2009
1	GlucosidasesIBA 01/2021
1	coumarinIBA 01/2021
1	kaempferolIBA 12/2019
1	tilirosideIBA 12/2019
1	helichrysosideIBA 12/2019
1	p-coumaric acidIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Pharmaceutical PreparationsIBA 02/2019
1	NitratesIBA 02/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2018
1	Immunoglobulin E (IgE)IBA 03/2018
1	AntigensIBA 03/2018
1	Hexosaminidase A (Hex A)IBA 03/2018
1	omega-Chloroacetophenone (Mace)IBA 03/2018
1	CarbonIBA 01/2018
1	ArbutinIBA 12/2017
1	DiterpenesIBA 12/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2017
1	1'-acetoxychavicol acetateIBA 07/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2017
1	U 0126 (UO 126)IBA 07/2017
1	PolyketidesIBA 01/2017
1	Growth InhibitorsIBA 01/2017
1	AcetoneIBA 12/2016
1	gallocatechol (epigallocatechin)IBA 11/2016
1	floratheasaponin AIBA 11/2016
1	TriterpenesIBA 07/2016
1	SaponinsIBA 07/2016
1	oleananeIBA 07/2016
1	xanthoneIBA 05/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2015
1	CytokinesIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	LipopolysaccharidesIBA 06/2014
1	GalactosamineIBA 06/2014
1	AlkaloidsIBA 02/2013
1	Hexosaminidases (Hexosaminidase)IBA 12/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2008
1	Proteins (Proteins, Gene)FDA Link 04/2004
1	Minocycline (Cyclops)FDA LinkGeneric 04/2004

Therapy/Procedure

1	Ayurvedic Medicine (Siddha Medicine) 06/2021
1	Electrodes (Electrode) 01/2018
1	Drug Therapy (Chemotherapy) 07/2017
1	Therapeutics 01/2016